Erratum to: Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

J Neurooncol

Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.

Published: May 2017

Download full-text PDF	Source
http://dx.doi.org/10.1007/s11060-017-2485-x	DOI Listing

Publication Analysis

erratum rapid

rapid progression

progression intracranial

intracranial melanoma

melanoma metastases

metastases controlled

controlled combined

combined braf/mek

braf/mek inhibition

inhibition discontinuation

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!